News
11-04-2010, 05:20 AM
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported financial results and operational highlights for the quarter ended September 30, 2010.
More... (http://www.news-medical.net/news/20101104/Synta-reports-24103M-net-loss-for-third-quarter-2010-vs-241181M-net-income-for-third-quarter-2009.aspx)
More... (http://www.news-medical.net/news/20101104/Synta-reports-24103M-net-loss-for-third-quarter-2010-vs-241181M-net-income-for-third-quarter-2009.aspx)